Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: John Rowton who wrote (11998)	12/2/1997 8:52:00 PM
From: Hippieslayer	Read Replies (2) \| Respond to of 32384

You could call tony bearish or just realistic. I, like others on this thread, would love to see lgnd go up to the mid 20's and 30's. The price justification is purely based upon the strategic alliances and the deal just completed with LLY. But, I-like tony and possibly others-understand that LGND will "float" until it has a drug approved or until a slew of + news comes out or if other alliances with up front cash payments to LGND are announced. I am very upset with how lgnd has responded in lite of the LLY news. But I bought the stock with the intentions of holding long term so I'll have to endure the violent ups and downs this stock. As well, an astute person can see that the trading range of lgnd has predominantly been between roughly 9/9.5 and 17.5/18 for over a year. If this trends continues, one can successfully trade this stock and make some good money. That is if you have a stong stomach to do so and if you guess right on which way the stock is going!